Stay updated with breaking news from John Beigel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Gilead Sciences Inc. is recalling 55,000 vials of the COVID-19 drug remdesivir in the US after after a complaint about glass particles was confirmed by a company investigation.
WASHINGTON - Millions more people in the United States will soon be able to receive an extra dose of any coronavirus vaccine, regardless of their initial vaccination - a flexibility that comes along with the authorization Wednesday of the Moderna and Johnson & Johnson booster shots by federal regulators.
But before more people roll up their sleeves, the U.S. CDC will consult experts this week before finalizing official recommendations for who should get boosters and when.
New CDC data suggests the single-shot vaccine has the highest rate of breakthrough infections.
New research shows that there were few safety issues when mixing and matching vaccines for booster doses, and the immune responses appear to be more potent.